RecruitingNCT02461446

Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

Sponsor

Boston Children's Hospital

Enrollment

170 participants

Start Date

May 1, 2015

Study Type

OBSERVATIONAL

Conditions

PTEN Autism PTEN Hamartoma Tumor Syndrome ASD Macrocephaly

Summary

The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and maintaining a biorepository and linked phenotypic database for PTEN ASD.

Eligibility

Min Age: 18 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with asd, autism, and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Months and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.